rs25409

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_021912.5(GABRB3):​c.31C>T​(p.Pro11Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00436 in 1,575,188 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0035 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0044 ( 17 hom. )

Consequence

GABRB3
NM_021912.5 missense

Scores

1
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:12O:1

Conservation

PhyloP100: 1.08

Publications

30 publications found
Variant links:
Genes affected
GABRB3 (HGNC:4083): (gamma-aminobutyric acid type A receptor subunit beta3) This gene encodes a member of the ligand-gated ionic channel family. The encoded protein is one the subunits of a multi-subunit chloride channel that serves as the receptor for gamma-aminobutyric acid, a major inhibitory neurotransmitter of the mammalian nervous system. This gene is located on the long arm of chromosome 15 in a cluster with two other genes encoding related subunits of the family. This gene may be associated with the pathogenesis of several disorders including Angelman syndrome, Prader-Willi syndrome, nonsyndromic orofacial clefts, epilepsy and autism. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2013]
GABRB3 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 43
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • epilepsy, childhood absence, susceptibility to, 5
    Inheritance: AD, Unknown Classification: DEFINITIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006672621).
BP6
Variant 15-26773694-G-A is Benign according to our data. Variant chr15-26773694-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 16191.
BS2
High AC in GnomAd4 at 532 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021912.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRB3
NM_021912.5
c.31C>Tp.Pro11Ser
missense
Exon 1 of 9NP_068712.1X5DQY4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRB3
ENST00000299267.9
TSL:1
c.31C>Tp.Pro11Ser
missense
Exon 1 of 9ENSP00000299267.4P28472-2
GABRB3
ENST00000541819.6
TSL:1
c.249-922C>T
intron
N/AENSP00000442408.2F5H7N0
GABRB3
ENST00000638099.1
TSL:5
c.-20+249C>T
intron
N/AENSP00000490678.1A0A1B0GVW3

Frequencies

GnomAD3 genomes
AF:
0.00349
AC:
530
AN:
152068
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00497
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.000195
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00544
Gnomad OTH
AF:
0.00479
GnomAD2 exomes
AF:
0.00291
AC:
528
AN:
181554
AF XY:
0.00305
show subpopulations
Gnomad AFR exome
AF:
0.000854
Gnomad AMR exome
AF:
0.00321
Gnomad ASJ exome
AF:
0.00332
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000726
Gnomad NFE exome
AF:
0.00472
Gnomad OTH exome
AF:
0.00350
GnomAD4 exome
AF:
0.00445
AC:
6331
AN:
1423012
Hom.:
17
Cov.:
32
AF XY:
0.00442
AC XY:
3109
AN XY:
704018
show subpopulations
African (AFR)
AF:
0.00113
AC:
37
AN:
32788
American (AMR)
AF:
0.00343
AC:
134
AN:
39112
Ashkenazi Jewish (ASJ)
AF:
0.00472
AC:
120
AN:
25410
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37884
South Asian (SAS)
AF:
0.00112
AC:
91
AN:
80998
European-Finnish (FIN)
AF:
0.000813
AC:
40
AN:
49214
Middle Eastern (MID)
AF:
0.00347
AC:
19
AN:
5478
European-Non Finnish (NFE)
AF:
0.00513
AC:
5607
AN:
1093188
Other (OTH)
AF:
0.00480
AC:
283
AN:
58940
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
300
601
901
1202
1502
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
224
448
672
896
1120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00350
AC:
532
AN:
152176
Hom.:
3
Cov.:
32
AF XY:
0.00332
AC XY:
247
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.00101
AC:
42
AN:
41546
American (AMR)
AF:
0.00497
AC:
76
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
17
AN:
3470
East Asian (EAS)
AF:
0.000196
AC:
1
AN:
5112
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4824
European-Finnish (FIN)
AF:
0.000942
AC:
10
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00547
AC:
372
AN:
67988
Other (OTH)
AF:
0.00474
AC:
10
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
26
52
79
105
131
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00417
Hom.:
0
Bravo
AF:
0.00376
ESP6500AA
AF:
0.00116
AC:
5
ESP6500EA
AF:
0.00528
AC:
45
ExAC
AF:
0.00235
AC:
274
Asia WGS
AF:
0.000873
AC:
3
AN:
3452

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
2
not specified (2)
-
-
1
Epilepsy, childhood absence, susceptibility to, 1 (1)
-
-
1
Epilepsy, childhood absence, susceptibility to, 1;C2677087:Epilepsy, childhood absence, susceptibility to, 5 (1)
-
1
-
Epilepsy, childhood absence, susceptibility to, 5 (2)
-
-
1
Epilepsy, childhood absence, susceptibility to, 5;C4310712:Developmental and epileptic encephalopathy, 43 (1)
-
-
1
GABRB3-related disorder (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.10
CADD
Benign
17
DANN
Benign
0.95
Eigen
Benign
-0.89
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.44
T
MetaRNN
Benign
0.0067
T
MetaSVM
Benign
-0.99
T
PhyloP100
1.1
PROVEAN
Benign
0.49
N
REVEL
Uncertain
0.44
Sift
Benign
0.70
T
Sift4G
Benign
0.75
T
Polyphen
0.14
B
Vest4
0.19
MVP
0.97
ClinPred
0.0029
T
GERP RS
2.2
PromoterAI
-0.017
Neutral
Mutation Taster
=79/21
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs25409; hg19: chr15-27018841; COSMIC: COSV54658863; COSMIC: COSV54658863; API